4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-017559
EVP and General Counsel sold 3,970 shares at $138.17 ($548,535)
- EVP and General Counsel acquired 10,136 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Parschauer Karah Herdman · EVP and General Counsel
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-01 | Grant or award : show line 1 in the form | +5,500 | 29,561 | D | ||
| 2021-03-01 | Grant or award : show line 2 in the form | +4,636 | 34,197 | D | ||
| 2021-03-01 | Sale : show line 3 in the form | −3,970 | $138.17 | $548,535 | 30,227 | D |
| Open-market sales · 3,970 sh · avg $138.17 · $548,535 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-01 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +11,000 | 11,000 | D |
Loading xslF345X03/doc4.xml…